Don't miss the opportunity to join us at our in-person Masterclass for the opportunity to learn more!
Browser View
This sponsored message does not reflect the opinion of CIRSE, nor does it engage their responsibility
|
Do you care about safety profile in AV fistula stenosis?
|
|
AVeNew is the first large, prospective randomized trial studying whether a covered stent would provide a benefit compared to PTA for the treatment of AV Fistula stenosis.
|
|
Are you in Lisbon at CIRSE 2024?
Don't miss the opportunity to join us at our in-person Masterclass for the opportunity to learn more!
|
|
Title: Evidences and Clinical impact for covered stent in Vascular Access
Date: Tuesday 17th September, 2024
Time: 13:30 - 15:30 WEST
Location: Room 1.05, 1st Floor
|
|
Space is limited and subject to first come first served.
|
|
Enrol to gain access to the AVeNEW 24-month data trial and the opportunity to register your interest for our in-person Masterclass at CIRSE 2024.
|
|
![]() |
M. Tozzi Italy
|
![]() |
B. Dolmatch USA
|
|
|
You have received this sponsored message as a part of our mailing list service. If you wish to unsubscribe from CIRSE congress related notifications, sponsored messages and other promotional emails, you may UNSUBSCRIBE at any time
unsubscribe
|
|